Lanean...

Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer

There is firm evidence that PSA velocity is statistically associated with many prostate cancer outcomes, including those related to early detection. But clinical use of a marker depends on clinical as well as statistical significance. Before using PSA velocity to inform decisions such as whether or...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile nagusia: Vickers, Andrew J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054698/
https://ncbi.nlm.nih.gov/pubmed/23486455
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!